I’m a PhD-trained medical writer specializing in oncology, market access, HTA, and clinical evidence communication.
I support pharmaceutical, biotechnology, consultancy, CRO, and medical communications teams in transforming complex clinical, scientific, and health-economic evidence into clear, accurate, and strategically focused materials for payers, reviewers, clinicians, and other healthcare decision-makers.
My work sits at the intersection of scientific interpretation, evidence synthesis, and communication. I go beyond summarizing data to understand what the evidence means, how strong it is, and how to communicate it to the decision-making audience.
What I Do
I support the development of payer- and reimbursement-focused materials, including:
- AMCP and formulary dossier content
- Global Value Dossiers
- HTA and JCA evidence writing
- Payer-focused value narratives
- Integration of clinical and health-economic evidence into market access materials
- Clinical Evidence & Evidence Strategy
I synthesize and interpret clinical and scientific evidence to support clear, defensible narratives, including:
- Treatment landscapes
- Unmet-need narratives
- Comparative efficacy and safety reviews
- Targeted literature reviews
- PICO-based evidence synthesis
- Clinical trial evidence interpretation
- Evidence gap identification
- Medical Communications
I also support related scientific and medical communications, including:
- Scientific slide decks
- Manuscripts and abstracts
- Advisory board materials
- MSL and KOL materials
- Congress materials
- Publication-related content
How I Work
My background in translational medicine and oncology research gives me a strong understanding of how scientific evidence is generated before it reaches the page. When reviewing evidence, I consider:
- Study design
- Patient population
- Endpoints
- Comparators
- Statistical and clinical relevance
- Limitations
- Treatment context
- Consistency across the evidence base
This allows me to build narratives that are scientifically accurate, appropriately balanced, and focused on what matters to the intended audience.
What Clients Can Expect
My aim is not simply to make scientific content sound better.
I help clients turn complex evidence into communication that is easier to review, understand, and use in high-stakes healthcare decision-making.
That means:
- Clearer evidence narratives
- Stronger scientific interpretation
- More focused payer and stakeholder communication
- Accurate integration of evidence from multiple sources
- Less unnecessary back-and-forth during review
- Writing that remains rigorous without becoming unnecessarily complex
Let’s Work Together
If you need support with oncology, market access, HTA/JCA, AMCP or formulary dossiers, Global Value Dossiers, clinical evidence synthesis, payer-focused communication, or related medical communications, I’d be happy to discuss your project.